Now in charge of his seventh club, the Lommel head coach says fellow English managers should consider working overseas ...

The company is facing a combination of slow revenue growth, unresolved legal battles over talc products, and looming drug ...

Former Texas guard Tre Johnson is reportedly performing well in workouts and improving his stock ahead of the draft on ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $100.92, with a ...

According to Benzinga Pro, Johnson & Johnson's peer group average for short interest as a percentage of float is 4.04%, which ...

Johnson & Johnson is an impeccable dividend stock with a streak of 63 consecutive dividend raises. The company's long history ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

Fintel reports that on June 20, 2025, Oppenheimer downgraded their outlook for Johnson Controls International (NYSE:JCI) from ...

Boost your dividend portfolio with Allianz & LVMH. Read more on high yields, growth potential, and diversification for ...

Telemedicine company Hims & Hers Health has been one of the hottest healthcare stocks in recent memory. Changes at ...